Skip to main content
Journal ArticleOPEN ACCESS

A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide

  • Christenheit A
Global Journal of Cancer Therapy (2016) 009-018
DOI: 10.17352/gjct.000008
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Background: Despite the crucial role of integrin receptors in cancer pathogenesis and massive efforts towards establishing clinically relevant drugs, to the present no effective integrin antagonist for the treatment of malignant diseases has been introduced into the clinic.

Cite

CITATION STYLE

APA

Christenheit, A. (2016). A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide. Global Journal of Cancer Therapy, 009–018. https://doi.org/10.17352/gjct.000008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free